Filtered By:
Cancer: Brain Cancers
Drug: Dexamethasone
This page shows you your search results in order of date.
Order by Relevance | Date
Total 56 results found since Jan 2013.
Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)
CONCLUSION: Atezolizumab plus carboplatin and pemetrexed demonstrates activity in patients with advanced nonsquamous NSCLC with untreated brain metastases with an acceptable safety profile.PMID:37603816 | DOI:10.1200/JCO.22.02561
Source: Clinical Lung Cancer - August 21, 2023 Category: Cancer & Oncology Authors: Ernest Nadal Delvys Rodr íguez-Abreu Marta Sim ó Bartomeu Massut í Oscar Juan Gerardo Huidobro Rafael L ópez Javier De Castro Anna Estival Joaqu ín Mosquera Ivana Sullivan Enriqueta Felip Ana Blasco Maria Guirado Eva Pereira Noelia Vilari ño Valent Source Type: research
Development of a Rabbit Human Glioblastoma Model for Testing of Endovascular Selective Intra-Arterial Infusion (ESIA) of Novel Stem Cell-Based Therapeutics
CONCLUSIONS: The intracranial immunosuppressed rabbit human GBM model allows testing of ESIA infusion of novel therapeutics (e.g., MSC-D24) in a clinically relevant fashion.PMID:37603323 | DOI:10.1093/neuonc/noad152
Source: Ann Oncol - August 21, 2023 Category: Cancer & Oncology Authors: Peter Kan Visish M Srinivasan Joy Gumin Roberto Garcia Stephen R Chen Jeremiah N Johnson Dalis E Collins Melissa M Chen Daniel Ledbetter Jason Huse Zean Aaron Evan Luna Ariadna Robledo Viren Vasandani Abhijit Rao Sanjay K Singh Elizabeth J Shpall Juan Fue Source Type: research
The Impact of Resistance Exercise on Muscle Mass in Glioblastoma in Survivors (RESIST): Protocol for a Randomized Controlled Trial
CONCLUSIONS: This study will inform how individualized circuit-based resistance training may improve functional independence and overall QOL of glioblastoma patients.TRIAL REGISTRATION: ClinicalTrails.gov NCT05116137; https://www.clinicaltrials.gov/ct2/show/NCT05116137.INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/37709.PMID:35507403 | DOI:10.2196/37709
Source: Cancer Control - May 4, 2022 Category: Cancer & Oncology Authors: Melanie R Keats Scott A Grandy Christopher Blanchard Jonathon R Fowles Heather F Neyedli Adrienne C Weeks Mary V MacNeil Source Type: research
Central and peripheral effects of environmental enrichment in a mouse model of arthritis
This study analyzed whether environmental enrichment (EE) modulates the nociceptive and inflammatory responses in the mouse model of arthritis induced by Complete Freund's Adjuvant (CFA). Ninety male mice (C57BL/6-JUnib, 4-weeks-old; 20-25 g) were distributed into EE and standard (SE) groups. For EE, mice were kept in bigger cages using an alternation of materials to chew (wood and paper), for nesting (cotton), to use as hiding places (plastic tunnels), and for voluntary exercise (wheel running). Arthritis was induced by an injection of CFA (50 μL) into the right hind paw or saline solution in the control group. Separate ...
Source: International Immunopharmacology - November 26, 2021 Category: Allergy & Immunology Authors: Marina Estr ázulas Raquel D S Freitas Eduarda T K äfer Ana P A Dagnino Maria M Campos Source Type: research
Efficacy of Shouzhangshen (Rhizoma Gymnadeniae Crassinervidis) extract against acute high altitude hypoxia-induced brain injury in mice
CONCLUSION: Our findings suggest that Shouzhangshen extract may have a significant effect on acute high altitude hypoxia-induced brain injury in mice.PMID:34392647 | DOI:10.19852/j.cnki.jtcm.2021.03.007
Source: Journal of Traditional Chinese Medicine - August 15, 2021 Category: Complementary Medicine Authors: Yong-Cang Zhang Tong-Hua Liu Lan Liu Yong-Hua Zong Yu Li Hai Xiong Li-Li Wu Source Type: research
